Intratympanic Botulinum Toxin Injection as a New Therapeutic Modality for Middle Ear Myoclonic Tinnitus
- 30 January 2023
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 169 (2) , 348-357
Abstract
Objective: Middle ear myoclonic tinnitus (MEMT) is a disease caused by myoclonus or abnormal contractive movement of middle ear muscles (MEMs). This translational study was conducted to propose intratympanic botulinum toxin (IT‐BTX) injection as a new therapeutic modality to treat MEMT.Study Design: Animal experiment and nonrandomized controlled clinical trial.Setting: Laboratory and medical center of an academic tertiary medical institution.Methods: For the animal study, male Sprague‐Dawley rats were divided into 4 subgroups according to the sacrificing day after IT‐BTX injection. After initial hearing tests, randomly assigned experimental ears were intratympanically injected with 1 unit/100 μL of BTX‐A, whereas control ears were injected with normal saline. Changes in the hearing thresholds, morphometry of the cochleae, electron microscopy study, and immunofluorescence analysis of MEMs were evaluated. For the human study, 10 intractable MEMT patients were enrolled. The hearing thresholds and the degree of tinnitus distress were observed for changes after IT‐BTX injection. All patients were followed up for 3 months.Results: As for the animal study, there were no significant changes in hearing thresholds and cochlear morphologies in all 4 subgroups of the rats. Significant MEM degenerations and immuno‐detection of cleaved synaptosome‐associated protein of 25 kDa (cSNAP‐25) indicated the efficacy of IT‐BTX. MEMT patients enrolled for the pilot clinical trial showed statistically significant improvement in tinnitus after IT‐BTX injection. No major complications were noted.Conclusion: The new therapeutic modality of IT‐BTX injection for the treatment of MEMT seems highly promising with an excellent result.Keywords
This publication has 18 references indexed in Scilit:
- Botulinum toxins: Mechanisms of action, antinociception and clinical applicationsToxicology, 2013
- Comparison of functional and morphologic characteristics of mice models of noise-induced hearing lossAuris Nasus Larynx, 2013
- Systematic Review of Management Strategies for Middle Ear MyoclonusOtolaryngology–Head and Neck Surgery, 2012
- Botox transient treatment of tinnitus due to stapedius myoclonus: Case reportClinical Neurology and Neurosurgery, 2011
- Intratympanic application of botulinum toxin: experiments in guinea pigs for excluding ototoxic effects2007
- Objective high-frequency tinnitus of middle-ear myoclonusThe Journal of Laryngology & Otology, 2004
- Bilateral Myoclonus of the Tensor Tympani: A Case ReportOtolaryngology–Head and Neck Surgery, 2003
- Management of middle ear myoclonusThe Journal of Laryngology & Otology, 1994
- Tinnitus related to eyelid blinkingThe Journal of Laryngology & Otology, 1992
- The supression of palatal (or intra-tympanic) myclonus by tinnitus masking devicesThe Journal of Laryngology & Otology, 1987